Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis

Overview of attention for article published in Frontiers in Pharmacology, February 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,774 followers.

New Research: Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis https://t.co/UMR6Q15JY7 #pharmacology

14 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.